Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited 0241.HK Peers
See (0241.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0241.HK | HK$4.65 | -4.32% | 76.4B | 47.40 | HK$0.10 | N/A |
| 6160.HK | HK$145.00 | -1.63% | 210.6B | -67.18 | -HK$2.20 | N/A |
| 3613.HK | HK$8.86 | +2.78% | 7.3B | 14.45 | HK$0.60 | +4.04% |
| 1345.HK | HK$2.10 | -2.33% | 2.5B | 15.21 | HK$0.14 | +4.88% |
| 3390.HK | HK$0.37 | -1.35% | 330.8M | 37.00 | HK$0.01 | N/A |
| 1110.HK | HK$0.57 | +0.00% | 324.3M | 6.88 | HK$0.08 | +5.76% |
| 2211.HK | HK$1.11 | -1.77% | 93.7M | 4.88 | HK$0.24 | N/A |
| 0348.HK | HK$0.07 | +0.00% | 53.9M | -1.40 | -HK$0.05 | N/A |
| 0574.HK | HK$0.03 | -3.23% | 42.8M | -2.90 | -HK$0.01 | N/A |
Stock Comparison
0241.HK vs 6160.HK Comparison
0241.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0241.HK stands at 76.4B. In comparison, 6160.HK has a market cap of 210.6B. Regarding current trading prices, 0241.HK is priced at HK$4.65, while 6160.HK trades at HK$145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0241.HK currently has a P/E ratio of 47.40, whereas 6160.HK's P/E ratio is -67.18. In terms of profitability, 0241.HK's ROE is +0.08%, compared to 6160.HK's ROE of -0.12%. Regarding short-term risk, 0241.HK is less volatile compared to 6160.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0241.HK.